Topic Hub

Comparing semaglutide and tirzepatide

Questions visitors usually ask before choosing between Eden's two compounded GLP-1 paths: price, fit, support, and what changes after provider review.

Many high-intent visitors are not deciding whether GLP-1 is interesting in general. They are deciding whether Eden's semaglutide or tirzepatide path makes more sense for their goals and budget.

Key questions
  • How does the first-month price differ between Eden's two paths?
  • What does provider review determine before a prescription is written?
  • What support and shipping details stay the same across both options?
The price gap is part of the decision

Semaglutide is positioned as the lower-entry option, while tirzepatide carries a higher first-month and recurring rate. Many visitors want that comparison surfaced early.

The provider still decides fit

A visitor cannot self-select medication just because it appears on the page. A licensed provider reviews the health profile and decides what is appropriate to prescribe.

Shared logistics still matter

Both paths use the same online intake, self-pay framing, pharmacy delivery model, and ongoing support language, so the comparison is not just about medication names.

Proof Pages

Trust pages connected to this cluster